News

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...
Tirzepatide decreased participants’ calorie intake by reducing appetite while increasing fat oxidation. However, the drug did not decrease the slowing down of their metabolic rate usually observed ...
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
GLP-1s such as semaglutide and tirzepatide, originally formulated to treat patients with diabetes, have been touted as a solution for weight loss.
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...